SCHEMBL2236124

SCHEMBL2236124

O=CCc1ccc([N+](=O)[O-])cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
ERN1 O75460 1/20 0.41
ALDH1A1 P00352 6/20 0.41
TDP1 Q9NUW8 3/20 0.41
CYP3A4 P08684 2/20 0.41
TSHR P16473 3/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GLA P06280 1/20 0.39
PTPRC P08575 1/20 0.38
S100A4 P26447 1/20 0.38
PTPN1 P18031 1/20 0.37
PDE7A Q13946 1/20 0.37
GPR35 Q9HC97 2/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5748776 0.86 PTPRC (0.42) CYP1A2POLBERN1ALDH1A1TDP1
SCHEMBL9800931 0.81 CYP1A2 (0.41) CYP1A2POLBERN1ALDH1A1TDP1
SCHEMBL10033263 0.81 CYP1A2 (0.58) CYP1A2ERN1ALDH1A1TDP1CYP3A4
SCHEMBL30468473 0.80 CYP1A2 (0.45) CYP1A2POLBALDH1A1TDP1CYP3A4
SCHEMBL3379806 0.80 CYP1A2 (0.45) CYP1A2POLBALDH1A1TDP1CYP3A4
SCHEMBL1684411 0.80 ALDH1A1 (0.48) CYP1A2POLBALDH1A1TDP1CYP3A4
SCHEMBL1640597 0.79 ALDH1A1 (0.49) CYP1A2ERN1ALDH1A1TDP1CYP3A4
SCHEMBL30714466 0.79 HSD17B10 (0.56) CYP1A2POLBERN1ALDH1A1TDP1
SCHEMBL1195412 0.79 HSD17B10 (0.56) CYP1A2POLBERN1ALDH1A1TDP1
SCHEMBL14894155 0.79 ALDH1A1 (0.56) CYP1A2ERN1ALDH1A1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2739628-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2014-06-11 EP disclosed
EP-2739625-A1 CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2014-06-11 EP disclosed
WO-2013022818-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-14 WO disclosed
WO-2013022814-A1 CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-14 WO disclosed
EP-2534152-A1 MACROCYCLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2012-12-19 EP disclosed
EP-2534154-A1 MACROCYCLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2012-12-19 EP disclosed
WO-2011100402-A1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-08-18 WO disclosed
WO-2011100401-A1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-08-18 WO disclosed